Eksempler på brug af Int http på Engelsk og deres oversættelser til Dansk
{-}
-
Medicine
-
Colloquial
-
Official
-
Financial
-
Ecclesiastic
-
Official/political
-
Computer
Carla CIGNINI Enterprise DG Fax(32-2) 299 27 69 E-mail: Carla.Cignini@cec.eu. int http://www. e-gateway. net- Ε-gateway is an information site for SMEs that wish to learn about electronic commerce.
EU Cedefop European Centre for the Development of Vocational Training■ Mr Marc Willem, Head of Library& Documentation Service Tel.(30) 2310 49 00 79 Secretariat E mail: mwi@cedefop.eu. int http://www. cedefop.eu. int.
Fax(44-20) 74 18 86 68 E-mail: mail@emea.eu. int http://www. emea. eu. int© EMEA 2006 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged.
Fax(44-20) 74 18 86 68 E-mail: mail@emea. eu. int http://www. emea. eu. int EMEA 2005 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged Hexavac is a hexavalent vaccine which contains combined antigens derived from Corynebacterium diphtheriae, Clostridium tetani, Bordetella pertussis, hepatitis B virus, polio virus and Haemophilus influenzae type b.
Fax(44-20) 74 18 86 13 E-mail: mail@emea. eu. int http://www. emea. eu. int©EMEA 2006 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged.
Fax(44-20) 74 18 84 16 E-mail: mail@emea. eu. int http://www. emea. eu. int EMEA 2006 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged How has M-M-RVAXPRO been studied?
Fax(44-20) 74 18 86 68 E-mail: mail@emea. eu. int http://www. emea. eu. int©EMEA 2006 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged How has Puregon been studied?
Fax(44-20) 74 18 86 68 E-mail: mail@emea. eu. int http://www. emea. eu. int©EMEA 2006 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged What benefit has Competact shown during the studies?
Fax(44-20) 74 18 84 16 E-mail: mail@emea. eu. int http://www. emea. eu. int©EMEA 2006 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged What benefit has Tygacil shown during the studies?
Fax(44-20) 74 18 86 14 E-mail: mail@emea. eu. int http://www. emea. eu. int©EMEA 2006 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged What benefit has Regranex shown during the studies?
Fax(44-20) 74 18 86 68 E-mail: mail@emea. eu. int http://www. emea. eu. int©EMEA 2006 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged the day; and this gives Actraphane a longer duration of action.
Fax(44-20) 74 18 86 68 E-mail: mail@emea. eu. int http://www. emea. eu. int EMEA 2004 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged The final opinion was converted into a Decision by the European Commission on 28 April 2004.* Notes.
Fax(44-20) 74 18 86 68 E-mail: mail@emea. eu. int http://www. emea. eu. int EMEA 2004 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged The list of product names concerned is given in the Annex I.
Fax(44-20) 74 18 84 16 E-mail: mail@emea. eu. int http://www. emea. eu. int©EMEA 2006 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged How has Forcaltonin been studied?
Fax(44-20) 74 18 84 16 E-mail: mail@emea. eu. int http://www. emea. eu. int©EMEA 2006 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged prophylactic(prevention) treatment.
Fax(44-20) 74 18 8613 E-mail: mail@emea. eu. int http://www. emea. eu. int©EMEA 2006 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged During the studies, the use of Photodynamic Therapy was permitted in addition to Macugen/ sham intervention.
Fax(44-20) 75 23 71 29 E-mail: mail@emea. eu. int http://www. emea. eu. int©EMEA 2006 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged The application was at Day 172 days, when the Company withdrew it.
Fax(44-20) 74 18 86 13 E-mail: mail@emea. eu. int http://www. emea. eu. int©EMEA 2006 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged given as separate eye drops.
Fax(44-20) 74 18 84 16 E-mail: mail@emea. eu. int http://www. emea. eu. int©EMEA 2006 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged What were the major concerns which led the CHMP to recommend the refusal of the marketing authorisation?
Fax(44-20) 74 18 84 16 E-mail: mail@emea. eu. int http://www. emea. eu. int©EMEA 2006 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged The effectiveness of Baraclude in chronic hepatitis B was compared with that of lamivudine in 3 main clinical studies.
Fax(44-20) 74 18 84 16 E-mail: mail@emea. eu. int http://www. emea. eu. int©EMEA 2006 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged or in patients with long-term kidney failure and other conditions, anaemia can be caused by a lack of erythropoietin, or by the body not responding enough to the erythropoietin it has naturally.
Fax(44-20) 74 18 86 13 E-mail: mail@emea. eu. int http://www. emea. eu. int©EMEA 2006 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged not prevent the granting of a Marketing Authorisation and that the Summary of Product Characteristics, labelling and package leaflet of the Reference Member State should be amended.